Showing results (1291-1300 of 1,376) with videos related to
Sort By:
Pageof 138
Physical Review Letters|August 6, 2013
Probing time-dependent molecular dipoles on the attosecond time scaleCh Neidel, J Klei, C-H Yang, et al.The Lancet. Neurology|March 17, 2018
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extensionRaju Kapoor, Pei-Ran Ho, Nolan Campbell, et al.Neurology|September 4, 2016
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MSDouglas L Arnold, Elizabeth Fisher, Vesna V Brinar, et al.Neurology|December 23, 2021
Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut MicrobiomeAli I Mirza, Feng Zhu, Natalie Knox, et al.Archives of Biochemistry and Biophysics|December 24, 2025
Adrenodoxin alters human cytochrome P450 27A1 structure and reaction efficiency beyond supplying electronsQuoc T Vu, Katherine C May, Leonard B Collins, et al.Chemical Science|August 16, 2024
4f-Orbital mixing increases the magnetic susceptibility of Cp'3EuS Olivia Gunther, Yusen Qiao, Patrick W Smith, et al.Multiple Sclerosis and Related Disorders|May 2, 2022
The metabolic potential of the paediatric-onset multiple sclerosis gut microbiomeAli I Mirza, Feng Zhu, Natalie Knox, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 studyRobert T Naismith, Jerry S Wolinsky, Annette Wundes, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension studyRalf Gold, Douglas L Arnold, Amit Bar-Or, et al.Critical Care (London, England)|November 28, 2017
High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trialKevin K Chung, Elsa C Coates, David J Smith, et al.Pageof 138